Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Rose

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Obstetrical & Gynecological Survey|August 29, 2001
Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent diseaseT C Krivak, G S Rose, J W McBroom, et al.
Gynecologic Oncology|October 5, 2001
Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survivalT C Krivak, J D Seidman, J W McBroom, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 21, 2006
Hematologic changes after splenectomy for cytoreduction: implications for predicting infection and effects on chemotherapyM A Bidus, T C Krivak, R Howard, et al.
Gynecologic Oncology|June 1, 2000
p27 and cyclin D1 abnormalities in uterine papillary serous carcinomaM J Schmitz, D T Hendricks, J Farley, et al.
American Journal of Obstetrics and Gynecology|July 14, 1998
The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum periodD Ahdoot, K M Van Nostrand, N J Nguyen, et al.
American Journal of Obstetrics and Gynecology|September 1, 1996
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 ratG S Rose, L M Tocco, G A Granger, et al.
Anticancer Research|February 24, 2001
Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancerN G Cloven, A Re, M T McHale, et al.
Cancer Research|June 5, 2001
Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factorT C Krivak, J W McBroom, J Seidman, et al.
International Journal of Cancer|March 1, 1996
Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancersA D Santin, G S Rose, J C Hiserodt, et al.
Gynecologic Oncology|July 1, 1997
In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA)A L Major, G S Rose, C F Chapman, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Obstetrical & Gynecological Survey|August 29, 2001
Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent diseaseT C Krivak, G S Rose, J W McBroom, et al.
Gynecologic Oncology|October 5, 2001
Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survivalT C Krivak, J D Seidman, J W McBroom, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 21, 2006
Hematologic changes after splenectomy for cytoreduction: implications for predicting infection and effects on chemotherapyM A Bidus, T C Krivak, R Howard, et al.
Gynecologic Oncology|June 1, 2000
p27 and cyclin D1 abnormalities in uterine papillary serous carcinomaM J Schmitz, D T Hendricks, J Farley, et al.
American Journal of Obstetrics and Gynecology|July 14, 1998
The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum periodD Ahdoot, K M Van Nostrand, N J Nguyen, et al.
American Journal of Obstetrics and Gynecology|September 1, 1996
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 ratG S Rose, L M Tocco, G A Granger, et al.
Anticancer Research|February 24, 2001
Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancerN G Cloven, A Re, M T McHale, et al.
Cancer Research|June 5, 2001
Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factorT C Krivak, J W McBroom, J Seidman, et al.
International Journal of Cancer|March 1, 1996
Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancersA D Santin, G S Rose, J C Hiserodt, et al.
Gynecologic Oncology|July 1, 1997
In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA)A L Major, G S Rose, C F Chapman, et al.
Pageof 3